Xolair (anti IgE antibodies) - a promissing approach to treat severe form of bronchial asthma

Abstract

Difficult to treat bronchial asthma responses to the treatment by Xolair which is humanized monoclonal antibody directed to IgE immunoglobulins.

Keywords

• alleric asthma
• treatment
• anti Ige
• Xolair